Literature DB >> 29246538

Sumoylation and ubiquitylation crosstalk in the control of ΔNp63α protein stability.

Michela Ranieri1, Maria Vivo2, Marco De Simone3, Luisa Guerrini4, Alessandra Pollice5, Girolama La Mantia5, Viola Calabrò5.   

Abstract

ΔNp63α is finely and strictly regulated during embryogenesis and differentiation. ΔNp63α is the only p63 isoform degraded by the proteasome after Ubiquitin and SUMO (Small Ubiquitin-like MOdifier) conjugation. Here, we show that p63 ubiquitylation per se is not the signal triggering p63 proteasomal degradation. Taking advantage of natural ΔNp63α mutants isolated by patients with Split Hand and Foot Malformation IV syndrome, we found that SUMO and Ub modifications are not redundant and both are required to guarantee efficient ΔNp63α degradation. Here, we present evidence that sumoylation and ubiquitylation of ΔNp63α are strongly intertwined, and none of the two can efficiently occur if the other is impaired.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Differentiation; GAM1; SFHM-IV syndrome; SUMO; Ubc9; p14ARF

Mesh:

Substances:

Year:  2017        PMID: 29246538     DOI: 10.1016/j.gene.2017.12.018

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  11 in total

1.  The significance of SUMOylation of angiogenic factors in cancer progression.

Authors:  Mei Wang; Xiaodong Jiang
Journal:  Cancer Biol Ther       Date:  2018-09-27       Impact factor: 4.742

2.  Comprehensive clinical and molecular studies in split-hand/foot malformation: identification of two plausible candidate genes (LRP6 and UBA2).

Authors:  Kaori Yamoto; Hirotomo Saitsu; Gen Nishimura; Rika Kosaki; Shinichiro Takayama; Nobuhiko Haga; Hidefumi Tonoki; Akihisa Okumura; Emiko Horii; Nobuhiko Okamoto; Hiroshi Suzumura; Shiro Ikegawa; Fumiko Kato; Yasuko Fujisawa; Eiko Nagata; Shuji Takada; Maki Fukami; Tsutomu Ogata
Journal:  Eur J Hum Genet       Date:  2019-07-22       Impact factor: 4.246

3.  Distinct interactors define the p63 transcriptional signature in epithelial development or cancer.

Authors:  Rosalba Pecorari; Francesca Bernassola; Gerry Melino; Eleonora Candi
Journal:  Biochem J       Date:  2022-06-30       Impact factor: 3.766

Review 4.  The Role of Mutant p63 in Female Fertility.

Authors:  Yi Luan; Pauline Xu; Seok-Yeong Yu; So-Youn Kim
Journal:  Int J Mol Sci       Date:  2021-08-20       Impact factor: 5.923

Review 5.  Dual Role of the Alternative Reading Frame ARF Protein in Cancer.

Authors:  Rosa Fontana; Michela Ranieri; Girolama La Mantia; Maria Vivo
Journal:  Biomolecules       Date:  2019-03-04

6.  The p63 C-terminus is essential for murine oocyte integrity.

Authors:  Anna Maria Lena; Valerio Rossi; Susanne Osterburg; Artem Smirnov; Christian Osterburg; Marcel Tuppi; Angela Cappello; Ivano Amelio; Volker Dötsch; Massimo De Felici; Francesca Gioia Klinger; Margherita Annicchiarico-Petruzzelli; Herbert Valensise; Gerry Melino; Eleonora Candi
Journal:  Nat Commun       Date:  2021-01-15       Impact factor: 14.919

7.  PKC Dependent p14ARF Phosphorylation on Threonine 8 Drives Cell Proliferation.

Authors:  Rosa Fontana; Daniela Guidone; Felicia Sangermano; Viola Calabrò; Alessandra Pollice; Girolama La Mantia; Maria Vivo
Journal:  Sci Rep       Date:  2018-05-04       Impact factor: 4.379

Review 8.  Dynamics of p14ARF and Focal Adhesion Kinase-Mediated Autophagy in Cancer.

Authors:  Rosa Fontana; Maria Vivo
Journal:  Cancers (Basel)       Date:  2018-06-29       Impact factor: 6.639

9.  Oxidative Stress Causes Enhanced Secretion of YB-1 Protein that Restrains Proliferation of Receiving Cells.

Authors:  Andrea Maria Guarino; Annaelena Troiano; Elio Pizzo; Andrea Bosso; Maria Vivo; Gabriella Pinto; Angela Amoresano; Alessandra Pollice; Girolama La Mantia; Viola Calabrò
Journal:  Genes (Basel)       Date:  2018-10-22       Impact factor: 4.096

10.  TRIM8 Blunts the Pro-proliferative Action of ΔNp63α in a p53 Wild-Type Background.

Authors:  Mariano Francesco Caratozzolo; Flaviana Marzano; Daniela Isabel Abbrescia; Francesca Mastropasqua; Vittoria Petruzzella; Viola Calabrò; Graziano Pesole; Elisabetta Sbisà; Luisa Guerrini; Apollonia Tullo
Journal:  Front Oncol       Date:  2019-11-05       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.